Amanote Research
Register
Sign In
Biocompatible ELR-Based Polyplexes Coated With MUC1 Specific Aptamers and Targeted for Breast Cancer Gene Therapy
doi 10.1021/acs.molpharmaceut.5b00712.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Overexpression of Caveolin-1 in Inflammatory Breast Cancer Cells Enables IBC-specific Gene Delivery and Prodrug Conversion Using Histone-Targeted Polyplexes
Biotechnology and Bioengineering
Applied Microbiology
Biotechnology
Bioengineering
Targeted Therapy for Breast Cancer Prevention
Frontiers in Oncology
Cancer Research
Oncology
410. pDMAEMA-Based Polyplexes as Vectors for Retinal Gene Therapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Targeted Therapy for HER2 Positive Breast Cancer
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
CXCR4-targeted Therapy in Breast Cancer
The Lancet Oncology
Oncology
Screening of Immunosuppressive Factors for Biomarkers of Breast Cancer Malignancy Phenotypes and Subtype-Specific Targeted Therapy
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Promoters With Cancer Cell-Specific Activity for Melanoma Gene Therapy
Acta Naturae
Biochemistry
Biotechnology
Molecular Medicine
Molecular Biology
Ferromagnets-Based Multifunctional Nanoplatform for Targeted Cancer Therapy
